##gff-version 3
##sequence-region Q96N21 1 525
Q96N21	UniProtKB	Chain	1	525	.	.	.	ID=PRO_0000286678;Note=AP-4 complex accessory subunit Tepsin	
Q96N21	UniProtKB	Domain	8	141	.	.	.	Note=ENTH	
Q96N21	UniProtKB	Region	467	477	.	.	.	Note=Interaction with AP4B1;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26542808,ECO:0000269|PubMed:26756312;Dbxref=PMID:26542808,PMID:26756312	
Q96N21	UniProtKB	Region	515	525	.	.	.	Note=Interaction with AP4E1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Compositional bias	193	225	.	.	.	Note=Ser-rich	
Q96N21	UniProtKB	Compositional bias	365	431	.	.	.	Note=Pro-rich	
Q96N21	UniProtKB	Modified residue	333	333	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:23186163;Dbxref=PMID:18691976,PMID:23186163	
Q96N21	UniProtKB	Modified residue	356	356	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18220336,ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18220336,PMID:18691976,PMID:20068231,PMID:23186163	
Q96N21	UniProtKB	Alternative sequence	1	85	.	.	.	ID=VSP_025141;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q96N21	UniProtKB	Alternative sequence	86	175	.	.	.	ID=VSP_025142;Note=In isoform 2. FFLLILKRNSAFIQEAAAFAGPPDPLHGNSLYQKVRAAAQDLGSTLFSDTVLPLAPSQPLGTPPATGMGSQARPHSTLQGFGYSKEHGRT->MGSQARPHSTLQGFGYSKEHGRTGSAGEAFLSTIQKAAEVVASAMRPGPESPSTRRLLPRGDTYQPAMMPSASHGPPTLGNLLPGAIPGPR;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q96N21	UniProtKB	Mutagenesis	467	467	.	.	.	Note=No effect on interaction with AP4B1 in vitro. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	468	468	.	.	.	Note=No effect on interaction with AP4B1 in vitro. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	469	469	.	.	.	Note=No effect on interaction with AP4B1 in vitro. S->A%2CP;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	470	470	.	.	.	Note=Loss of interaction with AP4B1 n vitro. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	470	470	.	.	.	Note=Loss of interaction with AP4B1 in vitro%3B when associated with S-471. L->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26756312;Dbxref=PMID:26756312	
Q96N21	UniProtKB	Mutagenesis	471	471	.	.	.	Note=Loss of interaction with AP4B1 in vitro. F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	471	471	.	.	.	Note=Loss of interaction with AP4B1 in vitro%3B when associated with S-470. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26756312;Dbxref=PMID:26756312	
Q96N21	UniProtKB	Mutagenesis	472	472	.	.	.	Note=No effect on interaction with AP4B1 in vitro. A->D%2CP;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	473	473	.	.	.	Note=No effect on interaction with AP4B1 in vitro. G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	473	473	.	.	.	Note=Loss of interaction with AP4B1 in vitro%3B when associated with Q-474. G->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26756312;Dbxref=PMID:26756312	
Q96N21	UniProtKB	Mutagenesis	474	474	.	.	.	Note=Decreased interaction with AP4B1 in vitro. M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	474	474	.	.	.	Note=Decreased interaction with AP4B1 in vitro%3B when associated with A-476. M->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26756312;Dbxref=PMID:26756312	
Q96N21	UniProtKB	Mutagenesis	474	474	.	.	.	Note=Loss of interaction with AP4B1 in vitro%3B when associated with I-473. M->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26756312;Dbxref=PMID:26756312	
Q96N21	UniProtKB	Mutagenesis	475	475	.	.	.	Note=No effect on interaction with AP4B1 in vitro. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	476	476	.	.	.	Note=No effect on interaction with AP4B1 in vitro. Decreased interaction with AP4B1%3B when associated with D-474. L->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26542808,ECO:0000269|PubMed:26756312;Dbxref=PMID:26542808,PMID:26756312	
Q96N21	UniProtKB	Mutagenesis	476	476	.	.	.	Note=Decreased interaction with AP4B1 in vitro%3B when associated with S-477. L->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26756312;Dbxref=PMID:26756312	
Q96N21	UniProtKB	Mutagenesis	477	477	.	.	.	Note=No effect on interaction with AP4B1 in vitro. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	477	477	.	.	.	Note=Decreased interaction with AP4B1 in vitro%3B when associated with S-476. V->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26756312;Dbxref=PMID:26756312	
Q96N21	UniProtKB	Mutagenesis	516	516	.	.	.	Note=No effect on interaction with AP4E1 in vitro. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	517	517	.	.	.	Note=No effect on interaction with AP4E1 in vitro. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	518	518	.	.	.	Note=Loss of interaction with AP4E1 in vitro. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	519	519	.	.	.	Note=Loss of interaction with AP4E1 in vitro. A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	520	520	.	.	.	Note=Loss of interaction with AP4E1 in vitro. F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	521	521	.	.	.	Note=No effect on interaction with AP4E1 in vitro. A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	522	522	.	.	.	Note=Loss of interaction with AP4E1 in vitro. F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	523	523	.	.	.	Note=Loss of interaction with AP4E1 in vitro. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	524	524	.	.	.	Note=Decreased interaction with AP4E1 in vitro. N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Mutagenesis	525	525	.	.	.	Note=No effect on interaction with AP4E1 in vitro. A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26542808;Dbxref=PMID:26542808	
Q96N21	UniProtKB	Helix	7	24	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5WFB	
Q96N21	UniProtKB	Beta strand	26	29	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5WFB	
Q96N21	UniProtKB	Helix	35	45	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5WFB	
Q96N21	UniProtKB	Helix	47	63	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5WFB	
Q96N21	UniProtKB	Helix	66	82	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5WFB	
Q96N21	UniProtKB	Helix	85	93	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5WFB	
Q96N21	UniProtKB	Helix	95	102	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5WFB	
Q96N21	UniProtKB	Turn	110	112	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5WFB	
Q96N21	UniProtKB	Helix	115	131	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5WFB	
